Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share News

TRADING UPDATES: Avingtrans HS2 win; Metals Exploration's Runruno blow

28th Aug 2025 11:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Solvonis shares jumps as touts positive results at PTSD therapy trials

12th Aug 2025 18:32

(Alliance News) - Solvonis Therapeutics PLC on Tuesday reported positive results from pre-clinical screening of a therapy for post-traumatic stress disorder. Read More

SMALL-CAP WINNERS & LOSERS: S&U hails motor finance verdict; Xaar down

12th Aug 2025 11:17

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

LONDON MARKET MIDDAY: Stocks red as "real concerns" on tariffs remain

11th Jul 2025 12:00

(Alliance News) - Stock prices in London were lower midday on Friday, after news of Donald Trump floating up to 20% blanket tariffs on some countries, and saying Canada will face a 35% levy effective from his latest August 1 deadline. Read More

SMALL-CAP WINNERS & LOSERS: Solvonis raises GBP1 million at premium

11th Jul 2025 10:35

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Solvonis Therapeutics raises GBP1.0 million for drug discovery scheme

11th Jul 2025 10:07

(Alliance News) - Solvonis Therapeutics PLC on Friday said it raised GBP1.0 million gross from subscriptions to new shares, and this will fund development of drugs treating addiction and other mental health disorders. Read More

Solvonis granted US patent for AI-led CNS compound programme

23rd Jun 2025 11:12

(Alliance News) - Solvonis Therapeutics PLC on Monday said the US Patent & Trademark Office has allowed a core patent application covering compounds in its artificial-intelligence-enabled central-nervous-system discovery programme, granting protection in the US's drug market for at least 18 years. Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

TRADING UPDATES: Ten Lifestyle celebrates new Japan contract win

11th Jun 2025 22:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Solvonis promotes Professor David Nutt to chief scientific officer

3rd Jun 2025 14:02

(Alliance News) - Solvonis Therapeutics PLC on Tuesday announced the appointment of neuroscience professor David Nutt as its chief scientific officer, with immediate effect. Read More

TRADING UPDATES: T42 IOT Tracking extends CLN repayment dates

16th May 2025 21:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

22nd Apr 2025 16:58

Read More

Solvonis shares fall with "high risk" that losses will continue

16th Apr 2025 14:05

(Alliance News) - Solvonis Therapeutics PLC said on Wednesday that it will be focusing on funding its research projects, after reporting no sources of revenue for its latest year. Read More

TRADING UPDATES: Knights Group seals buy; Kanabo position uncertain

4th Apr 2025 21:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Solvonis reports positive progress on European patent for Awakn collab

26th Mar 2025 13:43

(Alliance News) - Solvonis Therapeutics PLC on Wednesday reported "positive progress" on its European patent application for the Awkn-Sdn-14 programme. Read More

Solvonis to buy Awakn Life Sciences for around GBP5 million

24th Feb 2025 12:23

(Alliance News) - Solvonis Therapeutics PLC on Monday said it entered into an arrangement agreement to buy Toronto-based Awakn Life Sciences Corp. Read More

FTSE 100 Latest
Value9,216.82
Change-38.68